New way to see complex HCP sales

An Australian invention is helping pharmas navigate the complex sales environment for specialty treatments used in oncology and rare diseases that are delivered in hospitals.

Industry veteran Ben Manuele started Samson Specialty to solve the problems he encountered during 17 years in the pharma industry with Novartis and Pfizer, and rising to Director of Sales ANZ for Actelion, which was later bought by Johnson & Johnson.

"I think Pharma is overly focused on patient value," Manuele told Pharma in Focus. "We've had, as an industry, a strong focus on the patient, but we've not put enough attention into the stakeholders that treat patients."